You are here
SCR, INC.
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Development of SVAD System for HF Therapy
Amount: $320,765.00DESCRIPTION (provided by applicant): The objective of this proposal is to complete the engineering development and pre-clinical testing of the SCR SVAD system to provide partial cardiac assist in pati ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health -
Counterpulsation Device with Integrated EKG System for Chronic Partial Circulator
Amount: $1,583,137.00DESCRIPTION (provided by applicant): Heart failure (HF) remains one of the largest unsolved problems in health care today and continues to increase in incidence and cost ( 34.8 billion in US in 2008). ...
SBIRPhase II2012Department of Health and Human Services National Institutes of Health -
Counterpulsation Device with Integrated ECG Sensing
Amount: $238,527.00DESCRIPTION (provided by applicant): Counterpulsation with an intra-aortic balloon pump has been widely and successfully used as a short term treatment for both acute and chronic cardiac dysfunction. ...
SBIRPhase I2010Department of Health and Human Services National Institutes of Health -
Portable pneumatic driver for counterpulsation therapy
Amount: $1,580,460.00DESCRIPTION (provided by applicant): SCR, Inc. (Louisville, KY) is developing a chronic implantable CPD system to treat HF patients who may be responsive to long-term counterpulsation support. The CPD ...
SBIRPhase II2009Department of Health and Human Services National Institutes of Health -
Development of a Counterpulsation Therapy Device
Amount: $1,437,630.00DESCRIPTION (provided by applicant): SCR, Inc. (Louisville, KY) has developed a long-term implantable counterpulsation device (CPD) to treat heart failure (HF) patients who may be responsive to a mi ...
SBIRPhase II2008Department of Health and Human Services National Institutes of Health -
Portable pneumatic driver for counterpulsation therapy
Amount: $268,790.00DESCRIPTION (provided by applicant): The incidence of congestive heart failure (CHF) is increasing worldwide with over one million new cases diagnosed annually. Over the past 30 years, counterpulsatio ...
SBIRPhase I2007Department of Health and Human Services National Institutes of Health -
A counterpulsation device to promote myocardial recovery
Amount: $172,749.00DESCRIPTION (provided by applicant): The incidence of congestive heart failure (CHF) is increasing worldwide with over one million new cases diagnosed annually. Over the past 30 years, counterpulsatio ...
SBIRPhase I2006Department of Health and Human Services National Institutes of Health